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free to move into the nucleus and switch on
the expression of specific genes. The T cell
antigen receptor (TCR) signaling pathway
activates the IKK complex through two
caspase-recruitment domain (CARD)–con-
taining adaptor molecules, CARMA1 and
BCL10. These adaptor proteins do not di-
rectly activate IKK, which implies that oth-
er molecules must be involved. As the two
new studies show, MPC is one of these
molecules (3, 4).
Lymphomas can arise outside of the
lymph nodes in the intestinal mucosa–asso-
ciated lymphoid tissue (MALT) and are of-
ten associated with chromosomal translo-
cations. One gene characteristically found
at the t(11;18)(q21;q21) translocation
breakpoint in these tumors encodes MPC.
This finding suggests that MPC is involved
in signaling pathways that promote cell
proliferation or survival, especially in lym-
phocytes (7). The MPC protein contains a
caspase-like domain, two immunoglobulin-
like domains, and a death domain. Super-
ficially, these domains hint at a role in pro-
grammed cell death, but previous work has
shown that MPC binds to BCL10, a
CARD-containing adaptor protein that me-
diates TCR-induced activation of NF-κB.
In addition, the MALT lymphoma translo-
cations generate a chimeric protein con-
taining the amino-terminal portion of c-
IAP2 and the carboxyl-terminal caspase-
like domain of MPC that activates NF-κB,
promoting tumor formation. 
Using mice engineered to lack the gene
encoding MPC, the Dixit, and Mak groups
discovered that MPC is crucial for regulat-
ing NF-κB activity prompted by antigen re-
ceptor signaling in T and B cells. What is
most notable in the MPC-deficient mice is
that the abnormalities are highly selective.
This finding indicates that MPC subserves
only certain signals relayed through NF-κB.
MPC-deficient mice are healthy during de-
velopment and fertile, but manifest abnor-
malities in their lymphoid tissues. There are
alterations in early thymocyte subpopula-
tions and major deficits in marginal zone B
cells as well as in CD5+ B1 cells. Although
these mice exhibit abundant CD4+ and
CD8+ T lymphocytes, the selective nature of
the abnormalities in MPC-deficient animals
only becomes clear when the functions of
mature lymphocytes are analyzed. Ruefli-
Brasse, Dixit, and colleagues (3) found de-
fective antigen receptor signaling in both B
and T cells in their mice. Early tyrosine
phosphorylation events were normal, but
the induction of cytokines, lymphocyte pro-
liferation, and NF-κB activation were
markedly reduced. By contrast, Ruland,
Mak, and co-workers (4) found a defect in
TCR-mediated responses but little impair-
ment in B cell responses to antigen or
lipopolysaccharide. The decrease in CD5+
B cells in the Ruland et al. mice, also seen
in other mice with defective B cell receptor
signaling, suggests that further examination
of B cells might reveal subtle abnormalities.
Both groups found abnormal immune re-
sponses and other defects in their MPC-de-
ficient mice that resemble those in animals
lacking BCL10 or CARMA1. However,
MPC-deficient animals did not show any
defects in the activation of NF-κB by tumor
necrosis factor (TNF)–α or interleukin-1.
Finally, transfection experiments showed
that BCL10 operates upstream of MPC, be-
cause MPC (when fused to c-IAP2) could
induce NF-κB in the absence of BCL10 but
the reverse was not true. Hence, MPC may
be the linchpin linking BCL10 to the IKK
signaling module. Thus, MPC is selectively
important for NF-κB activation through
antigen receptor signaling but not cytokine
signaling.
It is intriguing that MPC harbors both a
caspase-like domain and a death domain.
Caspases are evolutionarily conserved pro-
teases that are key players in apoptosis.
Death domains link pro-apoptotic mem-
bers of the TNF receptor superfamily to
caspases through adaptor proteins. CARD-
containing proteins, c-IAP2, and death do-
mains found in MPC potentially connect
with several different apoptotic pathways.
Although MPC has no known proteolytic
activity, apoptotic signaling pathways
should be carefully examined in MPC-de-
ficient mice. However, recent evidence that
caspases play key roles in cellular activa-
tion suggests that the caspase-like domain
of MPC could promote activation pathways
and have nothing to do with apoptosis (8).
Domain sharing by components of lym-
phocyte activation/proliferation and apop-
tosis signaling pathways may be an evolu-
tionary convenience, or may be a way to
coregulate these processes during cell pro-
liferation. The MPC-deficient mice offer a
means to explore this question.
NF-κB occupies a central nexus in the
regulation of immune response signaling.
The two new studies elucidate how antigen
receptors communicate with nuclear genes
through NF-κB. However, key questions
remain: What are the specific functions of
the immunoglobulin, death, and caspase-
like domains of MPC? What is the stoi-
chiometry of the complete signaling com-
plex involving MPC, and how does it trig-
ger IKK activity? Are the alterations in B
cell development strictly secondary to de-
fective antigen receptor signaling? What
lessons can be learned by investigating the
involvement of translocated MPC in tumor
formation? Finally, the MPC-deficient
mice generated by the Dixit and Mak
groups may unveil new drug targets for
treating cancers of the immune system.
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A
poptosis is a physiological program of
cell suicide that directs engulfment
and safe destruction of cell corpses by
healthy neighboring cells or professional
phagocytic scavengers such as macrophages
(1). Cells dying by apoptosis provide molec-
ular instructions for their own funeral, some-
times releasing “come hither” signals that
summon scavenger cells (2). These phago-
cytes then recognize “eat me” flags, such as
phosphatidylserine (PS)—a phospholipid
normally limited to the inner leaflet of the
plasma membrane bilayer— that is displayed
prominently on the surface of dying cells. A
receptor (PSR) on macrophages that recog-
nizes PS (3) then orchestrates compliance
with the last line of the cellular suicide note:
“Don’t get angry when you dispose of me.”
This triggers suppressive pathways—such as
the release of transforming growth factor–β1
(TGF-β1)—that prevent phagocytes from
mounting a proinflammatory response to the
dying cells (1). Two new studies in this issue
using mice (4) and worms (5) lacking PSR
provide important insights into how PSR
governs the clearance of apoptotic cells.
Furthermore, one of these studies (4) reveals
a sinister postscript to the funeral invita-
tion—“Eat me or die.”
The PSR is one of a number of receptors
on phagocytic cells that have been implicat-
ed in the uptake of dying cells. In addition,
there are a variety of “bridging” molecules
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and “eat me” signals other than PS that are
also important players in this process (6).
The molecular structure of the PSR differs
from that of other scavenger receptors rec-
ognizing “altered self,” hinting that this re-
ceptor has additional functions. These may
include oxoglutarate-dependent dioxyge-
nase activity that is reminiscent of the pep-
tidyl hydroxylases involved in oxygen sens-
ing (7, 8). Even though it is expressed by
many cell types, the PSR has proved elusive
principally because the few anti-PSR anti-
bodies available are not ideal for tracking its
subcellular distribution. Indeed, some fea-
tures of PSR’s structure suggest that it may
be a nuclear protein rather than a transmem-
brane receptor (7, 8). Reassuringly, a
“knockout and rescue” experiment in the
developing worm by Wang and colleagues
on page 1563 of this issue (5) provides
strong evidence that PSR is indeed the
phagocytic receptor responsible for engulf-
ment of dying cells.
These investigators exploited a powerful
and predictable model of embryonic cell dele-
tion and clearance: that of the developing
worm Caenorhabditis elegans. The worm has
the added advantage of simplicity: Only a few
proteins are involved in the uptake of dying
cells, and most of those identified from mu-
tant screens are intracellular molecules that
induce cytoskeletal rearrangements in the
cells engulfing corpses (9). The worm pro-
teins CED-2, CED-5, CED-10, and CED-12
are structurally and functionally homologous
to the mammalian signaling molecules CrkII,
DOCK180, Rac guanosine triphosphatase,
and ELMO, respectively. Worm embryos de-
ficient in psr-1 (a PSR homolog) exhibit a
clear defect in the clearance of cell corpses.
This defect could be rescued by overexpres-
sion of ced-2, -5, -10, or -12 but not by over-
expression of the ced-6 or -7 genes in a paral-
lel pathway that is downstream of the scav-
enger receptor encoded by ced-1. Indeed, the
clearance defect in the psr-1 mutant was res-
cued not only by overexpression of wild-type
psr-1 but also by overexpression of human
PSR. This finding con-
firms that PSR does
participate in corpse en-
gulfment, engaging a
signaling pathway that
is crucial for rearrange-
ment of the cytoskele-
ton of phagocytic cells
so that they can sur-
round and “swallow”
doomed corpses. It will
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ill effects if their cell
corpses are not en-
gulfed. In contrast, the
nonengulfment of cell corpses profoundly
upsets higher organisms with their sophisti-
cated innate immune systems, which present
autoantigens derived from noningested apop-
totic cells to the adaptive immune system. For
example, mice lacking functional C1q—a
component of the complement cascade that
forms a bridge between macrophages and
apoptotic cells (10)—develop multisystem
autoimmune disease in response to demon-
strably defective clearance of dying cells.
In contrast to the worm subjects of Wang
et al., Li and colleagues (4) in their study of
PSR-deficient mice on page 1560 of this is-
sue find a dramatically different phenotype
during fetal development. These animals ex-
hibit fatal neonatal respiratory failure asso-
ciated with a reduction in the number of air-
ways formed and accumulation of non-
ingested dying cells, cellular debris, and re-
cruited inflammatory leukocytes in the de-
veloping lungs (see the figure). Perhaps the
PSR is particularly important for clearing
apoptotic cells from the developing lungs.
This would be consistent with the lack of ev-
idence of pathology in most other PSR-defi-
cient tissues (although the authors did not
undertake detailed searches for diminished
apoptotic cell clearance). Indeed, different
clearance mechanisms may predominate de-
pending on the tissue—for example, C1q-
deficient mice exhibit impaired clearance of
apoptotic cells from the peritoneum and kid-
ney but not from the skin. Whatever mecha-
nisms underlie the lung phenotype of PSR-
deficient mice, the new data establish PSR
at the epicenter of developmental and in-
flammatory lung diseases.
Unexpectedly, 15% of PSR-deficient mice
also exhibit hyperplastic brain malformations
due to overproliferation of brain cells. This
aberrant phenotype is also seen in mice lacking
the Apaf-1–caspase-9–caspase-3 apoptosome
pathway that normally mediates apoptotic
deletion of excess cells from the developing
brain. However, unlike these animals, affected
brains in PSR-deficient mice show increased
numbers of apoptotic cells and the recruitment
of macrophages. These observations imply that
in wild-type mice binding of dying cells to
macrophages may trigger macrophage-mediat-
ed killing of apoptotic cells as reported in hu-
man (11) and worm, a phenomenon termed
“grab and stab” (9). Alternatively, the brain
malformations seen in PSR-deficient animals
might reflect loss of a nonphagocytic PSR
function, such as oxygen sensing.
PSR is now established as a key player in
the clearance of dying cells during develop-
ment (4, 5). Animals engineered to have only
certain tissues deficient in PSR (conditional
knockouts) are needed to generate viable
adult mice in which the functions of PSR
during inflammation and immunity can be
tested. PSR and the downstream signaling
pathways that it shares with other suppres-
sive phagocytic receptors, such as the αv in-
tegrins, may represent new therapeutic tar-
gets for treating common inflammatory dis-
eases of the lung where leukocyte clearance
by apoptosis has gone awry.
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Neonatal lung failure in PSR-deficient mice. During lung development
in the mouse embryo, certain populations of epithelial and mesenchymal
cells undergo apoptosis as part of the sculpting process that forms the air-
ways. In mice lacking PSR, the corpses of apoptotic cells are not cleared ef-
ficiently and ultimately disintegrate. Such “secondary necrosis” releases
cell contents that may directly or indirectly incite inflammation (via
macrophage activation), resulting in the recruitment of neutrophils. In ad-
dition, binding of proteins called collectins by apoptotic cells may tether
dying cells to the proinflammatory macrophage receptor CD91, further
promoting the inflammatory cascade.
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